Home › Funds › Lion Point Capital, LP › HUMA

Lion Point Capital, LP position in HUMA

HUMACYTE INC · Health Care

Lion Point Capital, LP reported holding 650,000 shares of HUMA (HUMACYTE INC) in its Q2 2026 13F filing — a position valued at US$507K, representing 2.43% of its reported portfolio and ranking #17 among its reported holdings. Lion Point Capital, LP has disclosed HUMA holdings in 9 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)650.00K sh
Reported value held$507.26K
Portfolio Weight2.43%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Lion Point Capital, LP's HUMA position evolved

Lion Point Capital, LP first disclosed a stake in HUMA in Q3 2023 at 235,000 shares (US$689K). The position peaked in Q1 2024 at 235,000 shares, worth US$731K. Across 9 filings, Lion Point Capital, LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 650,000 shares valued at US$507K. Notable position changes include a 499% increase in Q4 2025 (shares fell 37% over the following quarter), a 30% increase in Q1 2026 (shares rose 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 235.00K $688.55K New
Q4 2023 235.00K $667.40K Hold
Q1 2024 235.00K $730.85K Hold
Q1 2025 83.50K $142.37K New
Q2 2025 83.50K $174.51K Hold
Q3 2025 83.50K $145.29K Hold
Q4 2025 500.00K $480.25K Add
Q1 2026 650.00K $394.36K Add
Q2 2026 650.00K $507.26K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HUMA and 13F data

HUMA (HUMACYTE INC) is a Health Care company. 26 other funds we track also report a position in HUMA — the largest reported positions include GREAT POINT PARTNERS LLC (US$2.9M), LuminArx Capital Management LP (US$507K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HUMA

All HUMA fund holders →

FAQ

How long has Lion Point Capital, LP held HUMA?

Lion Point Capital, LP has disclosed HUMA holdings in 9 of the last 12 reported quarters, going back to Q3 2023.

What is Lion Point Capital, LP's current position in HUMA?

As of Q2 2026, Lion Point Capital, LP holds 650.00K shares of HUMA (HUMACYTE INC), valued at $507.26K, representing 2.43% of its reported portfolio and ranking #17.

Has Lion Point Capital, LP been buying or selling HUMA?

In the latest 13F filing (Q2 2026), Lion Point Capital, LP held unchanged its position in HUMA. The position peaked in Q1 2024 at 235.00K shares.

Which other funds hold HUMA?

Other major institutional holders of HUMA include GREAT POINT PARTNERS LLC, LuminArx Capital Management LP, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.